Validating predictors of disease progression in a large cohort of primary-progressive multiple sclerosis based on a

Jan-Patrick Stellmann1, Anneke Neuhaus2, Christian Lederer3

  • 1Institute for Neuroimmunology and Clinical MS Research (inims), University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Plos One
|March 22, 2014
PubMed
Abstract